ABILITY OF THE NEW IMMUNOSTIMULATOR SAPOMAX TO STIMULATE A SPECIFIC IMMUNE RESPONSE TO GENE-ENGINEERED PROTEINS OF HEPATITIS-Reference-Cited by-同舟云学术

ABILITY OF THE NEW IMMUNOSTIMULATOR SAPOMAX TO STIMULATE A SPECIFIC IMMUNE RESPONSE TO GENE-ENGINEERED PROTEINS OF HEPATITIS

Published:2020 Issue: Volume: Page:214-216
ISSN:2312-640X
Container-title:BIOTECHNOLOGY: STATE OF THE ART AND PERSPECTIVES
language:ru
Short-container-title:

Author:

Turmagambetova А.¹,Alexyuk M.¹,Alexyuk P.¹,Sokolova N.¹,Zaitseva I.¹,Berezin V.¹

Affiliation:

1. Research and Production Center for Microbiology and Virology

Abstract

It was shown that adjuvant Sapomax effectively stimulates the formation of levels of various classes of immunoglobulins against gene-engineered proteins of the viruses of hepatitis B and C. Moreover, the absence of stimulation of IgG3 levels indicates the absence of allergic manifestations of the developed immunostimulator.

Funder

Ministry of Education and Science of the Republic of Kazakhstan

Publisher

CO LTD "EXPO-BIOHIM-TEXNOLOGIES"

Subject

General Medicine

Reference4 articles.

1. 1. Bigaeva E., Doorn Ev., Liu H., Hak E. Meta-Analysis on Randomized Controlled Trials of Vaccines with QS-21 or ISCOMATRIX Adjuvant: Safety and Tolerability. PLoS One. 2016. V. 5. P. 11(5):e0154757. doi: 10.1371/journal. pone.0154757.

2. 2. Berezin V.E., Bogoyavlenskiy A.P., Tolmacheva V.P., Makhmudova N.R., Khudyakova S.S. et al. Immunostimulating complexes incorporating Eimeria tenella antigens and plant saponins as effective delivery system for coccidia vaccine immunization. J Parasitol. 2008. V. 94. P. 381-385. doi: 10.1645/GE-1289.1.

3. 3. Turmagambetova A.S., Alexyuk P.G., Bogoyavlenskiy A.P., Zaitseva I.A., Omirtaeva E.S. et al. Adjuvant activity of saponins from Kazakhstani plants on the immune responses to subunit influenza vaccine. Arch Virol. 2017. V. 162. P. 3817-3826. doi: 10.1007/s00705-017-3560-53.

4. 4. Gordon D.L., Sajkov D., Honda-Okubo Y., Wilkse S.H., Abang M. et al. Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with AdvaxTM delta inulin adjuvant. Vaccine. 2016. V. 19. P. 3780–3786. doi:10.1016/j.vaccine.2016.05.071.